RxDoctor Payments Data
★ My doctorsLook up a doctor →

Cynthia Costa, MD

Neurology · North Kansas City, MONPI 1649558461

Payments from drug & device makers

$5,037in general payments, 2019–2025

Across 367 payments — averaging $13.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$576
  • AbbVie$486
  • Novartis$449
  • Sanofi$405
  • EMD Serono, Inc.$320
  • Avanir Pharmaceuticals, Inc.$309
  • plus $2K from 36 others

What the payments were for

  • Speaking & faculty fees$1373%
  • Food & beverage$4,90097%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen57$576
AbbVie(2 entities)35$486
Novartis32$449
Sanofi22$405
EMD Serono, Inc.25$320
Avanir Pharmaceuticals, Inc.44$309
Supernus Pharmaceuticals, Inc.19$287
Amgen17$276
UCB, Inc.18$221
CSL Behring7$159
Acorda Therapeutics, Inc6$137
Teva Pharmaceuticals USA, Inc.9$123
Grifols USA, LLC5$100
AstraZeneca(2 entities)5$96
Lundbeck LLC5$84
SK Life Science, Inc.3$83
E.r. Squibb & Sons, L.L.C.4$81
Lilly USA, LLC7$80
Eisai Inc.4$75
Upsher-smith Laboratories LLC4$75
Portola Pharmaceuticals, LLC4$71
Amneal Pharmaceuticals LLC4$58
Mallinckrodt Enterprises LLC3$45
Jazz Pharmaceuticals Inc.3$44
Acadia Pharmaceuticals Inc3$44
Boston Scientific3$37
Ipsen Biopharmaceuticals, Inc2$33
Microtransponder, Inc.1$28
Promius Pharma LLC1$28
Mallinckrodt Hospital Products Inc.2$27
MDD US Operations, LLC2$25
Bristol Myers Squibb1$22
Livanova USA, Inc.1$21
Harmony Biosciences LLC1$19
Inspire Medical Systems, Inc.1$17
Alnylam Pharmaceuticals Inc.1$16
GE HealthCare1$16
Neurocrine Biosciences, Inc.1$16
Assertio Therapeutics, Inc.1$14
Arbor Pharmaceuticals, Inc.1$13
Neurelis, Inc.1$12
Pfizer1$12

How this compares

$5,037 in reported general payments places this provider in the 65th percentile of 381 neurology providers in Missouri.

See all neurology providers in Missouri →

Medicare billing

Part B allowed, 2024
$98,627
Medicare patients
272
Services billed
797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in North Kansas City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →